Medicines-HGH-Contraception

Duphaston tablets 10mg contain dydrogesterone, a synthetic progesterone, used to treat a variety of conditions resulting from a lack of endogenous (naturally produced) progesterone, including menstrual disorders and endometriosis, and for hormone replacement therapy (HRT) and transgender hormone therapy.

Yaz birth control pills contain active ingredient ethinylestradiol (form of betadex clathrate), and Jesa also contains the active ingredient drospirenone.In addition, the composition of the tablets includes additional ingredients: corn starch, lactose monohydrate, magnesium stearate.The composition of the tablet coating includes hypromellose, titanium dioxide, talc, dye.

1 system contains: norelgestromin (NG) 6 mg, ethinyl estradiol (EE) 600 mcg;The composition of the base TTS: outer layer of pigmented low density polyethylene and the inner layer of polyester.The composition of the middle layer TTS: adhesive mixture of polyisobutylene-polybutene, crospovidone, non-woven material from polyester, lauryl lactate.The composition of the removable protective layer TTS: a film of polyethylene terephthalate, a coating of polydimethylsiloxane.Packaging3 pcs

One tablet contains 20 μg of ethinylestradiol and 150 μg of desogestrel.In addition: colloidal silicon dioxide, lactose, α-tocopherol, magnesium stearate, potato starch, stearic acid, povidone.

Cyproterone acetate, ethinyl estradiol, lactose monohydrate, sodium carboxymethyl starch, povidone, colloidal anhydrous silicon dioxide, colloidal aluminum oxide, magnesium stearate, succinic yellow, hypromellose, lactose monohydrate, macrogol, titanium dioxide, black oxide, black water.Tablets (placebo): lactose monohydrate, sodium carboxymethyl starch, povidone, colloidal anhydrous silica, colloidal aluminum oxide, magnesium stearate.

Tablets include active substances such as ethinylestradiol and levonorgestrel.Additional components include: talc, silicon dioxide colloid, lactose monohydrate, corn starch, magnesium stearate.The shell consists of sucrose, talc, titanium dioxide, macrogol 6000, iron oxide red, calcium carbonate, copovidone, colloidal silica, povidone, carmellose sodium.

Lindynette 30 - a contraceptive drug of combined action.

The composition of vaginal suppositories includes 18.9 mg of benzalkonium chloride and a mixture of triglycerides of natural saturated fatty acids of vitessol in the amount necessary to produce a single suppository with a mass of 1.71 to 1.89 g.

Modelle PRO - Monophasic oral contraceptive with anti-mineralocorticoid and anti-androgenic properties.The contraceptive effect of combined oral contraceptives is based on the interaction of various factors, the most important of which are the suppression of ovulation and changes in the properties of the cervical secretion, as a result of which it becomes less permeable to sperm.If used correctly, the Pearl Index (the number of pregnancies per 100 women per year) is less than 1. If you skip pills or use it incorrectly, the Pearl Index may increase.In women taking combined oral contraceptives, the menstrual cycle becomes more regular, less frequent painful menstruation, decreases the intensity of bleeding, which reduces the risk of anemia. In addition, according to epidemiological studies, the use of combined oral contraceptives reduces the risk of developing endometrial cancer and ovarian cancer.Drospirenone contained in the drug Modelle PRO, has antimineralocorticoid action. Prevents weight gain and edema associated with estrogen-induced fluid retention, which ensures a very good tolerability of the drug. Drospirenone has a positive effect on premenstrual syndrome (PMS). Clinical efficacy of Jess in alleviating the symptoms of severe PMS, such as severe psycho-emotional disorders, breast engorgement, headache, muscle and joint pain, weight gain, and other symptoms associated with the menstrual cycle, is shown.Drospirenone also has antiandrogenic activity and helps reduce acne, oily skin and hair. This action of drospirenone is similar to the action of natural progesterone produced by the body.Drospirenone does not have androgenic, estrogenic, glucocorticoid and antiglucocorticoid activity. All this combination with anti-mineralocorticoid and anti-androgenic effects provides Drospirenone with a biochemical and pharmacological profile similar to natural progesterone.

1 tablet contains:active ingredients: drospirenone 3 mg, ethinyl estradiol 0.03 mg;excipients: lactose monohydrate 60 mg, corn starch 12.77 mg, silicon dioxide colloid 0.8 mg, hypromellose-2910 1.6 mg, talc 1.2 mg, magnesium stearate 0.6 mg;film coat: opadry II yellow 31F82689 2.4 mg (hypromellose-2910 33%, lactose monohydrate 28%, titanium dioxide (E171) 22.5%, macrogol-6000 10%, talc 5%, iron dye oxide yellow (E172) 1.5%).

1 tablet - 2.5 mg of nomegastrol acetate and 1.55 mg of estradiol hemihydrate (1.5 mg of estradiol, respectively) are the active substances.Auxiliary Ingredients:    0.7 mg - talc;    14 mg of microcrystalline cellulose;    0,7 mg - magnesium stearate;    2,4 mg of crospovidone;    57.71 mg - lactose monohydrate;    0.44 mg of colloidal silicon dioxide.Sheath:    1.6 mg - opadrai II white.Placebo tablets:    0.7 mg - talc;    14 mg of microcrystalline cellulose;    0,7 mg - magnesium stearate;    2,4 mg of crospovidone;    61.76 mg of lactose monohydrate;    0.44 mg of colloidal silicon dioxide.Sheath:    2,4 mg - opadrai II yellow.

As active components in the composition of Jeanine includes 2 mg of dienogest and 30 μg of ethinyl estradiol.In addition to these substances, lactose in the form of monohydrate, potato starch, magnesium stearate, talc, gelatin are present in the tablet formulation. The shell is made using sucrose, dextrose, macrogol 35000, calcium carbonate, polyvidone, titanium dioxide, carnauba wax.

Angeliq Micro contains 17-estradiol, chemically and biologically identical to endogenous human estradiol, and synthetic progestogen drospirenone. 17-estradiol provides hormone replacement during and after menopause. The addition of drospirenone provides control over bleeding and counteracts the development of estrogen-induced endometrial hyperplasia.

I intrauterine device contains:    levonorgestrel 52 mg;    polydimethylsiloxane elastomer - 52 mg.

The composition of 1 tablet includes 750 mcg levonorgestrel, as well as silicon dioxide colloidal anhydrous, magnesium stearate, potato starch and corn, talc, lactose monohydrate.

The composition of Rigevidon includes the main components: ethinyl estradiol and levonorgestrel.Additional ingredients: magnesium stearate, corn starch, povidone, talc, lactose monohydrate, silicon dioxide colloid, sucrose, calcium carbonate, copovidone, titanium dioxide, macrogol 6000, carmellose sodium.